RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Nonmelanomatous Skin Cancer - Pipeline Review, Q4 2010
Dec 2010 - 26 pages - $500
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
Oct 2010 - 64 pages - $2,000
Nonmelanomatous Skin Cancer - Pipeline Review, Q2 2011
Apr 2011 - 42 pages - $500
Nonmelanomatous Skin Cancer - Pipeline Review, H2 2011
Aug 2011 - 42 pages - $500
Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Champions Biotechnology, Inc. (CSBR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 42 pages - $250
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Boso Clinical Oncology Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 22 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Human therapeutics del
Therapeutic target
Oncology del
Skin cancer del
Development phase
Preclinical del

Browse By

Therapeutic target
Basal cell carcinoma
Melanoma
Squamous cell carcinoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us